文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

右美托咪定与咪达唑仑对脓毒性休克患者血浆儿茶酚胺水平及血流动力学影响的比较研究

[Comparative study of dexmedetomidine vs. midazolam on plasma catecholamine levels and hemodynamics in patients with septic shock].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论脓毒性休克机械通气患者中,右美托咪定较咪达唑仑降低48小时血浆去甲肾上腺素、多巴胺及多巴酚丁胺水平,不增加外源性去甲肾上腺素用量,对血流动力学影响更小。

该研究纳入2018年1月至2019年12月贵州医科大学附属医院重症医学科收治的需有创机械通气且ICU停留超过48小时的脓毒性休克患者24例,右美托咪定组与咪达唑仑组各12例。动态记录入ICU后0、12、24、48、72小时血流动力学、乳酸、血气及血管活性药物剂量,以及0、24、48小时血浆儿茶酚胺水平。结果显示两组心率、中心静脉压、静脉-动脉二氧化碳分压差、氧合指数及乳酸动态趋势相似;右美托咪定组48小时血浆去甲肾上腺素、多巴胺、多巴酚丁胺水平显著低于咪达唑仑组,但维持平均动脉压65~75 mmHg所需去甲肾上腺素剂量两组相似。结论认为右美托咪定较咪达唑仑更能降低脓毒性休克患者血浆儿茶酚胺水平,不增加外源性去甲肾上腺素剂量,对血流动力学影响更小。

要点

  • 脓毒性休克机械通气患者中,右美托咪定组48小时血浆去甲肾上腺素、多巴胺、多巴酚丁胺水平均显著低于咪达唑仑组(均P<0.05)。
  • 右美托咪定组维持平均动脉压65~75 mmHg所需去甲肾上腺素剂量与咪达唑仑组相似[1 922(1 170,4 887)μg/kg vs. 2 466(2 043,3 438)μg/kg,P>0.05]。
  • 右美托咪定组48小时和72小时平均动脉压显著高于咪达唑仑组(95±10 vs. 86±10 mmHg,96±9 vs. 88±7 mmHg,均P<0.05)。
  • 两组机械通气时间、ICU死亡率、住院死亡率及丙泊酚、舒芬太尼用量差异均无统计学意义(均P>0.05)。
  • 右美托咪定组12小时中心静脉压和72小时静脉-动脉二氧化碳分压差显著高于咪达唑仑组(均P<0.05)。

适用人群与场景

  • 2018年1月至2019年12月贵州医科大学附属医院重症医学科收治的脓毒性休克患者,需有创机械通气且ICU停留超过48小时,接受右美托咪定或咪达唑仑镇静。

研究设计与关键结果

  • 研究类型为比较研究,共纳入24例患者,右美托咪定组12例,咪达唑仑组12例。
  • 两组心率、中心静脉压、静脉-动脉二氧化碳分压差、氧合指数及乳酸水平的动态趋势相似。
  • 右美托咪定组12小时中心静脉压和72小时静脉-动脉二氧化碳分压差显著高于咪达唑仑组[中心静脉压(mmHg):13±3 vs. 10±3;静脉-动脉二氧化碳分压差(mmHg):9.4±5.2 vs. 4.8±2.2,均P<0.05]。
  • 右美托咪定组48小时和72小时平均动脉压显著高于咪达唑仑组(mmHg:95±10 vs. 86±10,96±9 vs. 88±7,均P<0.05)。
  • 两组机械通气时间、ICU死亡率及住院死亡率差异无统计学意义[机械通气时间(天):5.6(3.8,9.5) vs. 10.5(5.9,15.0);ICU死亡率:16.7% vs. 33.3%;住院死亡率:25.0% vs. 41.7%,均P>0.05]。
  • 两组丙泊酚和舒芬太尼用量差异无统计学意义[丙泊酚(mg/kg):0(0,9.35) vs. 4.07(0,13.75);舒芬太尼(μg/kg):6.26(4.90,9.80) vs. 8.32(3.52,9.34),均P>0.05]。
  • 右美托咪定组48小时血浆去甲肾上腺素、多巴胺及多巴酚丁胺水平显著低于咪达唑仑组[去甲肾上腺素(ng/L):1 850.12(342.16,2 938.05) vs. 4 596.60(3 310.56,5 546.84);多巴胺(ng/L):119.10(60.47,200.71) vs. 275.40(214.61,418.88);多巴酚丁胺(ng/L):51.20(36.85,75.59) vs. 98.97(85.65,107.10),均P<0.05]。
  • 两组维持平均动脉压65~75 mmHg所需去甲肾上腺素剂量相似[μg/kg:1 922(1 170,4 887) vs. 2 466(2 043,3 438),P>0.05]。

证据类型、等级与局限

  • 证据类型:比较研究(单中心,样本量24例)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在脓毒性休克需有创机械通气的患者中,选用右美托咪定镇静可能较咪达唑仑降低48小时血浆儿茶酚胺水平,且不增加外源性去甲肾上腺素剂量,对血流动力学影响更小。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To compare the effects of dexmedetomidine (DEX) and midazolam on the endogenous plasma catecholamine levels and the dosage of exogenous norepinephrine (NE) to maintain blood pressure in patients with septic shock.

METHODS: From January 2018 to December 2019, patients admitted to the department of critical care medicine of the Affiliated Hospital of Guizhou Medical University who needed invasive mechanical ventilation and had a stay of more than 48 hours in the intensive care unit (ICU) for septic shock and received DEX or midazolam for sedation were enrolled in this study. The hemodynamic data, arterial blood lactic acid (Lac) level, arterial blood gas analysis and vasoactive drug dose at 0, 12, 24, 48, 72 hours after entering the ICU were dynamically recorded, and the plasma catecholamine levels at 0, 24, 48 hours after entering the ICU were recorded. The acute physiology and chronic health evaluation II (APACHE II) score and sequential organ failure assessment (SOFA) score on ICU-admission were calculated. The parameters of prognosis were collected.

RESULTS: A total of 24 patients were enrolled, 12 in the DEX group and 12 in the midazolam group. There were similar dynamic trends in heart rate (HR), central venous pressure (CVP), venous-arterial carbon dioxide pressure difference (Pv-aCO2), oxygenation index (PaO2/FiO2), and Lac level of patients between the two groups. Only the 12-hour CVP and 72-hour Pv-aCO2 in the DEX group were significantly higher than those in the midazolam group [CVP (mmHg, 1 mmHg = 0.133 kPa): 13±3 vs. 10±3, Pv-aCO2 (mmHg): 9.4±5.2 vs. 4.8±2.2, both P < 0.05], and the mean arterial pressure (MAP) of patients in the DEX group at 48 hours and 72 hours was significantly higher than that in the midazolam group (mmHg: 95±10 vs. 86±10, 96±9 vs. 88±7, both P < 0.05). There was no statistically significant difference in the duration of mechanical ventilation, ICU mortality or in-hospital mortality between the DEX group and the midazolam group [duration of mechanical ventilation (days): 5.6 (3.8, 9.5) vs. 10.5 (5.9, 15.0), ICU mortality: 16.7% vs. 33.3%, in-hospital mortality: 25.0% vs. 41.7%, all P > 0.05]. There was no significant difference in the dosage of propofol or sufentanil between the DEX group and the midazolam group [propofol (mg/kg): 0 (0, 9.35) vs. 4.07 (0, 13.75), sufentanil (μg/kg): 6.26 (4.90, 9.80) vs. 8.32 (3.52, 9.34), both P > 0.05]. The levels of plasma NE, dopamine and dobutamine in the DEX group at 48 hours were significantly lower than those in the midazolam group [NE (ng/L): 1 850.12 (342.16, 2 938.05) vs. 4 596.60 (3 310.56, 5 546.84), dopamine (ng/L): 119.10 (60.47, 200.71) vs. 275.40 (214.61, 418.88), dobutamine (ng/L): 51.20 (36.85, 75.59) vs. 98.97 (85.65, 107.10), all P < 0.05], but the amount of NE required to maintain MAP between 65 mmHg and 75 mmHg in the DEX group and the midazolam group was similar [μg/kg: 1 922 (1 170, 4 887) vs. 2 466 (2 043, 3 438), P > 0.05].

CONCLUSIONS: DEX can reduce plasma catecholamine levels in patients with septic shock more than midazolam, and does not increase the dose of exogenous NE, and has a smaller effect on hemodynamics in patients with septic shock than midazolam.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Yao L, Liu B, He T, et al. [Comparative study of dexmedetomidine vs. midazolam on plasma catecholamine levels and hemodynamics in patients with septic shock]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34955127. doi:10.3760/cma.j.cn121430-20210119-00105

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。